We propose that the predicted interaction between zma-miR156a-3p and BCL2 could represent a beneficial regulatory mechanism capable of fighting cancer progression, especially considering the established role of BCL2 in tumor cell survival. This evidence concerns the gene BCL2 and neoplasm.